Bluebird Bio Gene Therapies Show Promise Against Deadly Anemias

Bluebird Bio’s experimental gene therapy LentiGlobin is helping some patients with two life-threatening forms of inherited anemia avoid blood transfusions.

Read the full post on Forbes - Pharma & Healthcare

Matthew Herper, Forbes Staff